Seeking Alpha

Next stop Biogen: Carl Icahn's fight for seats on the board of Biogen Idec (BIIB) comes to a...

Next stop Biogen: Carl Icahn's fight for seats on the board of Biogen Idec (BIIB) comes to a vote Wednesday, June 3. He owns 5.6% of the biotech group. Proxy advisory service RiskMetrics Group is backing two of Icahn's nominees. Icahn gained a seat on Amylin's (AMLN) board this week and is lobbying to ouster top management at Enzon (ENZN).
Comments (1)
  • Tony Petroski
    , contributor
    Comments (6373) | Send Message
     
    Icahn. Isn't he the airline guy? Wow! This guy is versatile.
    29 May 2009, 08:29 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector